WOONSOCKET, R.I., March 12, 2013 /PRNewswire/ -- CVS Caremark (NYSE:CVS) will highlight how medication adherence plays a vital role in helping older Americans on their path to better health at the 2013 Annual American Society on Aging Conference, which is being held in Chicago this week.
CVS Caremark, a Titanium Sponsor of the conference, will also be participating in a number of general sessions and panels and will highlight its efforts to ensure customers and patients receive quality care and guidance as they age. David Casey, the company's Vice President of Workforce Strategies and Chief Diversity Officer, will open the March 12 General Session: Mysteries of Population Aging.
As a pharmacy innovation company, CVS Caremark is committed to developing new ways to lower costs and improve health. By advancing the understanding of medication adherence through research collaborations, the company is gathering important information about why some patients take their medications as prescribed and why others do not. CVS Caremark is also refining the ways it interacts with patients through proven programs, such as Pharmacy Advisor and Maintenance Choice, that help patients stay on their medications and improve health outcomes."People age 65 and older typically take two or three times as many medications as younger Americans," said Casey. "As we reinvent pharmacy care, we will continue to be a trusted health care partner to all of our customers, but particularly to aging Americans who are more likely to have chronic conditions and require more guidance." CVS Caremark is not only committed to its older customers and patients, it is also committed to recruiting mature workers and supporting older colleagues who are already part of the company. "At CVS Caremark, we believe talent is ageless. Our mature colleagues' knowledge and experience are important assets to our company. They provide us with insight into the best ways to serve our mature customers and sometimes become mentors to their younger colleagues," added Casey.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts